Search This Blog

Saturday, May 10, 2025

Reformers must win the ‘big, beautiful’ GOP Medicaid battle

 If Republicans are going to pass President Donald Trump’s “big, beautiful” tax- and spending-cut bill, they’ll have to have to reckon with a hard truth: Medicaid is not sacrosanct. 

At least, not the path that Democrats had set for the program in the Obama and Biden years — a path of rapid growth and ever-expanding coverage.

Indeed, slowing Medicaid’s growth is vital not just to keep the “big bill” numbers balanced, but to keeping the program faithful to its actual purpose: ensuring health care for the poor.  

From the ObamaCare law onward, Democrats national and state have messed with Medicaid to push, shove, sneak and creep the country ever closer toward full-on socialized medicine. 

That’s meant vastly expanding the rolls to include people too young and too rich, people the program was never meant to serve. 

Thanks to Obama’s Affordable Care Act, the federal government pays for 90% of the cost of “prime age” state enrollees in the program; the “expansion” part of Barack Obama’s signature law was a bribe to Dem constituencies.

It’s provided a monstrous incentive to swell the ranks, including with people above the income limit: In the Empire State, for example, the data suggests that as many as 3 million over-earners use the program. 

This failure directly contradicts the point of Medicaid, which was to cover care for the poor (as Medicare did for the elderly), not for everyone in every state, no matter their age and earning ability.  

The slowdown has to happen, including a federal push for states to get adults who are too young and too-rich off the rolls. 

To get there, of course, Republicans will have to face down an avalanche of negativity from congressional Dems: The endless expansion of Medicaid has been a pet project of theirs for two decades; the old guard and the young bloods are equally committed to it. 

Naturally, most of the press is already starting to play along, with straight-up propaganda attacking these necessary reforms. 

The truly tricky part, however, is going to be for Trump and Speaker Mike Johnson to turn around the GOPers already squawking, like Nebraska Rep. Don Bacon, who’s drawn a public redline of no more than $500 billion in reductions.

We get it: Many politicians don’t want their fingerprints anywhere near anything that even remotely resembles an entitlement cut.

But any Republicans who flinch at undoing Democrats’ stealth moves to lock in an ever-expanding welfare state might as well quit politics completely.

https://nypost.com/2025/05/10/opinion/why-reformers-must-win-the-big-beautiful-gop-medicaid-battle/

Restrictions lifted after 160,000 Spaniards confined due to toxic cloud

 An order was lifted on Saturday that had confined some 160,000 people in Spain's northeastern Catalonia region after a fire at an industrial estate caused a toxic cloud of chlorine, the regional government said.

"The fire in Vilanova i la Geltrú is STABILIZED," the Catalonian fire services posted on X. "We maintain 24 units on site. The fire has not affected the adjacent warehouses and we continue to work on extinguishing the fire."

The blaze at a swimming pool cleaning products firm started at 2:20 a.m. local time (0020 GMT) in Vilanova i la Geltru, a town 48 kilometers (30 miles) south of Barcelona.

Authorities had told people in the affected zone to stay home, before later lifting the sanction.

"If you are in the zone that is affected, do not leave your home or your place of work," the Civil Protection service posted on X earlier on Saturday.

"No casualties" had been reported, the fire service said on social media, adding that it had deployed a large number of units in order to manage the situation.

 A fire in a chemical company in  has caused a toxic cloud
A fire at an industrial estate caused a toxic cloud of chlorine over a wide areaImage: Kike Rincón/IMAGO/Europa Press

The fire service said it was "monitoring the blaze... for its toxic levels."

"It is very difficult for chlorine to catch fire but when it does so it is very hard to put it out," warehouse owner Jorge Vinuales Alonso told the radio station Rac1. He added that the cause of the blaze might have been a lithium battery.

Vilanova mayor Juan Luis Ruiz Lopez had earlier told the public broadcaster TVE that authorities would lift the emergency measure once the "toxic cloud" started "to dissipate.

https://www.dw.com/en/spain-curbs-lifted-after-toxic-smoke-confined-thousands/a-72500189

German prosecutors move to strip AfD lawmaker's immunity amid bribery probe

 Public prosecutors in Germany have moved to strip a politician from the far-right Alternative for Germany (AfD) of his immunity as a lawmaker after initiating a probe into bribery and money laundering allegations, local media reported on Friday.

Prosecutors in the eastern city of Dresden confirmed that an investigation had been initiated against a German lawmaker on charges of bribery while he was a member of the European Parliament as well as money laundering in connection with Chinese payments.

The prosecutors did not name the suspect.

According to the Sueddeutsche Zeitung newspaper, the probe is focused on Maximilian Krah, one of the new cohort of AfD politicians who entered the German parliament after February's federal election.

Krah's office was not immediately available for comment on the report, which was also carried by Der Spiegel magazine.

Last month German authorities arrested a former aide of Krah on suspicion of having used his position to gather information for the Chinese intelligence service and of spying on Chinese dissidents.

The man, identified as Jian G., obtained more than 500 documents to transfer to China, including some classified by the European Parliament as particularly sensitive, the federal prosecutors' office said in a statement.

Krah has not commented publicly on the case since his former aide's arrest. Two years ago, when a member of the European Parliament, he dismissed allegations then surfacing that his aide had been lobbying for China as slander against himself.

https://www.aol.com/news/german-prosecutors-move-strip-afd-115130855.html

France in talks with Britain, Ukraine about potential troops, Macron tells paper

 France is consulting with partners on how to potentially support Ukraine in its struggle with Russia with troops, French President Emmanuel Macron told newspaper Le Parisien on Saturday, without elaborating on what such a presence could include.

"We are working on the presence and strategic footprint of the partner countries. There have been several exchanges between our British, French and Ukrainian chiefs of staff, who have coordinated the work with all their partners, and all this is becoming clearer and making progress," Macron was cited in the article.

"The key is to have troops in Ukraine," he added.

Major European powers including France threw their weight behind an unconditional 30-day Ukraine ceasefire, with the backing of U.S. President Donald Trump.

Macron joined the leaders of Britain, Germany and Poland on a visit to Kyiv on Saturday during which they held a phone call with Trump

https://www.straitstimes.com/world/europe/france-in-talks-with-britain-ukraine-about-potential-troops-macron-tells-paper

Valneva (VALN) Faces U.S. Suspension for Chikungunya Vaccine in Seniors

 

  • U.S. health agencies advise pausing Valneva's chikungunya vaccine for ages 60+ due to safety concerns.
  • Valneva SE (VALNFinancial) shows a potential upside of 119.75% based on analyst price targets.
  • Current brokerage recommendations suggest an "Outperform" status for Valneva SE.

U.S. health agencies, including the CDC and FDA, have recommended a pause on the administration of Valneva’s (VALN) chikungunya vaccine, Ixchiq, for individuals aged 60 and older. This decision arises from safety concerns, with reports of 17 serious adverse events, including two fatalities, among vaccine recipients aged 62-89. The vaccine received approval in November 2023.

Valneva SE (VALNFinancial) is attracting significant attention with its one-year price targets projected by four analysts. The average target price is set at $14.22, presenting a high estimate of $17.93 and a low of $8.07. This forecast suggests a notable upside of 119.75% from the current trading price of $6.47. For investors seeking comprehensive estimate data, please refer to the Valneva SE (VALN) Forecast page.

The consensus from four brokerage firms positions Valneva SE (VALNFinancial) with an average recommendation of 1.8, signaling an "Outperform" rating. In this rating system, 1 represents a Strong Buy, and 5 indicates a Sell, highlighting the favorable outlook for this stock among analysts.

https://www.gurufocus.com/news/2851842/valneva-valn-faces-us-suspension-for-chikungunya-vaccine-in-seniors

U.S. pharma imports soar in March as drugmakers look to get ahead of potential tariffs

 Pharmaceutical imports to the U.S. jumped in March, according to the latest trade report by the Census Bureau and the Bureau of Economic Analysis, as drugmakers try to avoid any potential tariffs on the sector.

Total imports of pharmaceutical preparations came up to $50.42B in March, a $20.92B increase from February. YTD imports have now reached $108.20B in just a few months, nearly two times that of total imports of $54.87B in all of 2024. 

Imports from Ireland in particular increased to $30.73B in March from $15.27B in February. Ireland is a major hub for drug manufacturing, with household names such as Pfizer (PFE), AbbVie (ABBV) and Johnson & Johnson (JNJ) having significant operations there. 

"The key takeaway from the full March trade report was that the dramatic surge in front-loaded imports during the month was heavily driven by pharmaceuticals being flown in from Ireland, not piles of goods arriving from Asia by boat," JPMorgan said on Tuesday.

"Since some drug ingredients can be frozen for 3-4 years, it’s possible to bring in multiple years’ worth of supply now if it is available, and for tax reasons these imports are usually recorded near their retail price, which far exceeds the cost of production," JPMorgan added.

U.S. President Donald Trump has been mulling tariffs on pharmaceutical imports. Trump on Monday signed an executive order to encourage domestic production of pharmaceutical preparations.

"Because pharma imports are being heavily stockpiled for future use, they don’t have much of an implication for near-term domestic economic activity. They are not being integrated immediately into domestic manufacturing production, nor are they going into final consumption," JPMorgan said. 

"The pharma trade highlights a type of trade that is often arriving by air instead of by ship, and that is small in physical volume but high in price. April could be another strong month for imports with ships arriving from Asia and potentially more pharma imports coming in. Thereafter, vessel trade will likely fall off, but import values could continue to be supported by drug imports until tariffs on them kick in," JPMorgan added.

The S&P 500 Health Care sector is -3.72% YTD, while its accompanying Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV) is -3.55%.

Here are some exchange-traded funds linked to the Health Care sector: (NYSEARCA:VHT), (NYSEARCA:IHI), (NYSEARCA:IXJ), (NYSEARCA:IYH), (NYSEARCA:FHLC), and (NYSEARCA:FXH).

https://www.msn.com/en-us/money/markets/u-s-pharma-imports-soar-in-march-as-drugmakers-look-to-get-ahead-of-potential-tariffs/ar-AA1Exdc1

The missing recession

 by Bill Glahn

The headline from Wednesday’s New York Times,